Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,329,391 papers from all fields of science
Search
Sign In
Create Free Account
Cyclic Nucleotide Phosphodiesterases, Type 4
Known as:
Type 4 Cyclic Nucleotide Phosphodiesterase
, PDE4 Phosphodiesterases
, Phosphodiesterase IV
Expand
A cyclic nucleotide phosphodiesterase subfamily that is found predominantly in inflammatory cells and may play a role in the regulation of CELL…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Narrower (6)
Cyclic Nucleotide Phosphodiesterases, Type 4A
Cyclic Nucleotide Phosphodiesterases, Type 4C
Cyclic Nucleotide Phosphodiesterases, Type 4D
PDE4B protein, human
Expand
In Blood
Process of secretion
aspects of radiation effects
chemical synthesis
Expand
Broader (1)
phosphoric diester hydrolase
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Natural diarylfluorene derivatives: isolation, total synthesis, and phosphodiesterase-4 inhibition
Junsheng Zhang
,
Xin Liu
,
+5 authors
Sheng Yin
2017
Corpus ID: 99155669
In our previous study, selaginpulvilins A–D (1–4) featuring an unprecedented 9,9-diphenyl-1-(phenylethynyl)-9H-fluorene skeleton…
Expand
Review
2016
Review
2016
Improvement of Nail and Scalp Psoriasis Using Apremilast in Patients With Chronic Psoriasis: Phase 2b and 3, 52-Week Randomized, Placebo-Controlled Trial Results.
C. Nguyen
,
A. Leon
,
M. Danesh
,
Kourosh Beroukhim
,
Jashin J. Wu
,
J. Koo
Journal of Drugs in Dermatology
2016
Corpus ID: 8328690
INTRODUCTION A significant portion of patients with psoriasis have scalp and nail involvement. It has been reported that 40% to…
Expand
2015
2015
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate to severe psoriasis: 52-week results of the ESTEEM 2 Trial
C. Paul
,
M. Gooderham
,
+9 authors
J. Crowley
2015
Corpus ID: 196539149
2010
2010
Cross-talk between PI3-kinase and cAMP-Protein Kinase signaling pathways at the level of a Protein Kinase B / -arrestin / cAMP phosphodiesterase-4 complex
E. Bjørgo
,
Silje A. Solheim
,
+6 authors
K. Taskén
2010
Corpus ID: 91041112
2008
2008
Phosphodiesterase 4 inhibitors; current status
D. Spina
2008
Corpus ID: 88954645
2006
2006
Preliminary Study of Herbs on the Influence of Phosphodiesterase 4 Activity
Mu Xiang
2006
Corpus ID: 100536836
Selective herbal regulators of phosphodiesterase 4(PDE4) were sieved by the influence on PDE4 activity to supply evidence for the…
Expand
2004
2004
Phosphodiesterase 4 cAMP phosphodiesterases as targets for novel anti‐inflammatory therapeutics
S. Mackenzie
2004
Corpus ID: 86118149
Cyclic nucleotides are powerful signaling molecules and their sole means of removal is through the action of cyclic nucleotide…
Expand
2002
2002
AWD 12-281: Antiasthmatic/antiinflammatory phosphodiesterase 4 inhibitor
Hildegard Kuss
,
N. Höfgen
,
+12 authors
C. Rundfeldt
2002
Corpus ID: 72863730
Airway diseases such as bronchial asthma and chronic obstructive pulmonary disease (COPD) are chronic inflammatory diseases whose…
Expand
Review
2000
Review
2000
New phosphodiesterase inhibitors as therapeutics for the treatment of chronic lung disease.
M. Barnette
,
D. Underwood
Current opinion in pulmonary medicine
2000
Corpus ID: 24216393
Phosphodiesterase 4 (PDE4) is a member of the growing family cyclic AMP and cyclic GMP. Earliest described inhibitors of PDE4…
Expand
1998
1998
Inhibitory effects of rolipram on partially purified phosphodiesterase 4 from rat brains.
F. Ohsawa
,
Miki Yamauchi
,
H. Nagaso
,
S. Murakami
,
J. Baba
,
A. Sawa
Japanese Journal of Pharmacology
1998
Corpus ID: 24539385
Several previous studies have demonstrated that the phosphodiesterase 4 selective inhibitor rolipram affects cellular function at…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE